AIM ImmunoTech Inc. Quarterly Revenues in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
AIM ImmunoTech Inc. quarterly/annual Revenues history and growth rate from Q1 2010 to Q2 2024.
  • AIM ImmunoTech Inc. Revenues for the quarter ending June 30, 2024 was $50K, a 19% increase year-over-year.
  • AIM ImmunoTech Inc. Revenues for the twelve months ending June 30, 2024 was $201K, a 18.9% increase year-over-year.
  • AIM ImmunoTech Inc. annual Revenues for 2023 was $202K, a 43.3% increase from 2022.
  • AIM ImmunoTech Inc. annual Revenues for 2022 was $141K.
  • AIM ImmunoTech Inc. annual Revenues for 2018 was $367K, a 16% decline from 2017.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $201K $50K +$8K +19% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $193K $40K -$9K -18.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $202K $65K +$8K +14% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $194K $46K +$25K +119% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $169K $42K +$12K +40% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $157K $49K +$16K +48.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $141K $57K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $21K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $30K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $33K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2018 $38K -$52K -57.8% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $33K -$180K -84.5% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-14
Q3 2017 $90K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $213K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q3 2015 $146K $23K -$22K -48.9% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-16
Q2 2015 $168K $47K +$11K +30.6% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-12
Q1 2015 $157K $36K -$40K -52.6% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-12
Q4 2014 $197K $40K +$4K +11.1% Oct 1, 2014 Dec 31, 2014 10-K 2015-03-19
Q3 2014 $193K $45K +$9K +25% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 $184K $36K $0 0% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 $184K $76K +$34K +81% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 $150K $36K -$17K -32.1% Oct 1, 2013 Dec 31, 2013 10-K 2014-03-14
Q3 2013 $167K $36K -$3K -7.69% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $170K $36K -$13K -26.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $183K $42K -$30K -41.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $213K $53K +$15K +39.5% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 $198K $39K -$6K -13.3% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 $204K $49K +$13K +36.1% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 $191K $72K +$30K +71.4% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 $161K $38K +$11K +40.7% Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 $150K $45K +$10K +28.6% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-18
Q2 2011 $140K $36K -$5K -12.2% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-18
Q1 2011 $145K $42K +$10K +31.3% Jan 1, 2011 Mar 31, 2011 10-K 2013-03-18
Q4 2010 $135K $27K Oct 1, 2010 Dec 31, 2010 10-K 2013-03-18
Q3 2010 $35K Jul 1, 2010 Sep 30, 2010 10-K 2013-03-18
Q2 2010 $41K Apr 1, 2010 Jun 30, 2010 10-K 2013-03-18
Q1 2010 $32K Jan 1, 2010 Mar 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.